onureg 200 mg
bristol, myers squibb (israel) limited, israel - azacitidine - film coated tablets - azacitidine 200 mg - azacitidine - onureg is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (cr) or complete remission with incomplete blood count recovery (cri) following intensive induction chemotherapy and are not able to complete intensive curative therapy
onureg 300 mg
bristol, myers squibb (israel) limited, israel - azacitidine - film coated tablets - azacitidine 300 mg - azacitidine - onureg is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (cr) or complete remission with incomplete blood count recovery (cri) following intensive induction chemotherapy and are not able to complete intensive curative therapy
azacitidine seacross 25mg/ml powder for suspension for injection
seacross pharmaceuticals limited - azacitidine - powder for suspension for injection - 100mg
azacitidine 25 mg/ml powder for suspension for injection
clonmel healthcare ltd - azacitidine - powder for suspension for injection - azacitidine
efudix 5% w/w cream
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - cream - fluorouracil 5 % (w/w) - antineoplastic agents
decitabine - trima 50 mgvial
trima israel pharmaceutical products maabarot ltd - decitabine - powder for concentrate for solution for infusion - decitabine 50 mg - decitabine - decitabine trima is indicated for treatment of patients with myelodysplastic syndromes (mds) including previously treated and untreated, de novo and secondary mds of all french-american-british subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2 and high-risk international prognostic scoring system groups. decitabine trima is indicated for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia (aml), according to the world health organisation (who) classification, who are not candidates for standard induction chemotherapy
azacitidine sandoz 25 mg/ml powder for suspension for injection
sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - powder for suspension for injection - azacitidine 25 mg/ml - antineoplastic agents
capecitabine sun
sun pharmaceutical industries europe b.v. - capecitabine - stomach neoplasms; breast neoplasms; colonic neoplasms; colorectal neoplasms - capecitabine - capecitabine is indicated for the adjuvant treatment of patients following surgery of stage-iii (dukes’ stage-c) colon cancer.capecitabine is indicated for the treatment of metastatic colorectal cancer.capecitabine is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline. capecitabine is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.
gemcitabin "ebewe" 1000 mg/100ml
مستودع ادوية الصباغ - sabbagh drug store - gemcitabine 1000 mg/100ml - 1000 mg/100ml
gemcitabin "ebewe" 500 mg/50ml
مستودع ادوية الصباغ - sabbagh drug store - gemcitabine hcl 500 mg/50ml - 500 mg/50ml